COMMUNIQUÉS West-GlobeNewswire

United Health Products Issues Update on HemoStyp®South Korea MFDS Application

30/01/2018 - 14:30

HENDERSON, Nev., Jan. 30, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]

Haven® Sun Protectant Approved in California

30/01/2018 - 14:30

DAVIS, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]

Assure Holdings Performs First Neuromonitoring Case in Louisiana

30/01/2018 - 14:30

PARKER, Colo., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV:IOM) (OTCQB:ARHH), a provider of intraoperative neuromonitoring (IONM) services, has performed its first [...]

IN.PACT Admiral Demonstrates Consistent and Durable Outcomes in New Two-Year Japan Data and IN.PACT Global Critical Limb Ischemia Cohort Analysis

30/01/2018 - 14:29

Data Presented at LINC 2018 Highlight IN.PACT Admiral as Safe and Effective Treatment Option in PAD DUBLIN and LEIPZIG - January 30, 2018 - Medtronic plc (NYSE: MDT) today added to its robust body of clinical evidence [...]

athenahealth Recognized as Top Practice Management (11-75 Physicians) Service in 2018 KLAS Report

30/01/2018 - 14:05

WATERTOWN, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced top-performing [...]

Exonics Therapeutics Appoints Roger M. Perlmutter, M.D., Ph.D., to Board of Directors

30/01/2018 - 14:00

CAMBRIDGE, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Exonics Therapeutics, Inc., a biotechnology company focused on developing SingleCut CRISPR technology to repair mutations causing Duchenne muscular dystrophy and other [...]

Cambrex Expands Process Research and Development Capabilities Across North America

30/01/2018 - 14:00

EAST RUTHERFORD, N.J., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced an [...]

Tyme Announces Prostate Cancer Collaboration with Dr. Mack Roach III of UCSF

30/01/2018 - 14:00

NEW YORK, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced that Mack Roach III, M.D., FASTRO, FACR, [...]

Nu-Med Plus, Inc. announces trading on OTCQB Marketplace

30/01/2018 - 14:00

SALT LAKE CITY, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCBB: NUMD ), a medical device development company announced it has begun to have its securities designated and traded as OTCQB securities which will [...]

BioDelivery Sciences Announces Launch and Availability of BELBUCA® in Canada

30/01/2018 - 14:00

RALEIGH, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) and Purdue Pharma (Canada) announced today that BELBUCA® (buprenorphine) buccal film is now commercially [...]

Fibrocell Announces FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial of FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

30/01/2018 - 14:00

EXTON, Pa., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue, today announced [...]

Momenta Pharmaceuticals Announces Positive Outcome for Contracted Glatopa® (glatiramer acetate injection) Fill/Finish Manufacturer

30/01/2018 - 14:00

-- McPherson, Kansas facility compliance status amended to Voluntary Action Indicated (VAI)-- -- VAI status provides the potential for the near-term FDA approval of Sandoz’s Glatopa 40 mg ANDA-- CAMBRIDGE, Mass., Jan. [...]

CymaBay Announces Pricing of Public Offering of Common Stock

30/01/2018 - 14:00

NEWARK, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

First Patient Treated in Mapi Pharma’s Phase II Clinical Trial of GA Depot for Primary Progressive Multiple Sclerosis (PPMS)

30/01/2018 - 14:00

Study is being conducted on strength of prior Phase II clinical trial that showed strong efficacy in RRMS patients who switched from Copaxone ® to once-monthly GA Depot NESS ZIONA, Israel, Jan. 30, 2018 (GLOBE NEWSWIRE [...]

Emerald Health Therapeutics and Namaste Technologies Announce Letter of Intent for International Partnership and Supply Agreement

30/01/2018 - 13:30

VICTORIA, British Columbia and VANCOUVER, British Columbia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (“Emerald”) (TSXV:EMH) (OTCQX:EMHTF) and Namaste Technologies Inc. (“Namaste”) (CSE:N) ( [...]

REPEAT: Cannabis Wheaton Income Corp. Announces Expansion to Uruguay and Securing of Significant CBD-Rich Hemp Production

30/01/2018 - 13:30

VANCOUVER, British Columbia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or "Wheaton" or the " Company ") is pleased to announce that it has [...]

AB Biosciences and Shire Enter Into Agreement for Development and Commercialization of AB Biosciences' PRIM Program

30/01/2018 - 13:01

AB Biosciences and Shire Enter Into Agreement for Development and Commercialization of AB Biosciences' PRIM Program for Potential Treatment of Autoimmune Diseases and Other Immune-Mediated Disorders AB Biosciences to [...]

Madrigal Announces Acceptance of MGL-3196 Abstract for a Main Plenary Presentation at The International Liver Congress™ 2018

30/01/2018 - 13:00

CONSHOHOCKEN, Pa., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL ) today announced that Week 12 Phase 2 results for MGL-3196, its first-in-class, oral, once-daily, liver-directed, [...]

Revive Therapeutics Advances Research Program of Cannabinoid-Based Therapies Targeting Liver Diseases

30/01/2018 - 13:00

TORONTO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel [...]